Verastem Statistics
Total Valuation
Verastem has a market cap or net worth of $715.48 million. The enterprise value is $674.19 million.
Important Dates
The last earnings date was Tuesday, November 4, 2025, before market open.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Verastem has 77.18 million shares outstanding. The number of shares has increased by 100.55% in one year.
| Current Share Class | 77.18M |
| Shares Outstanding | 77.18M |
| Shares Change (YoY) | +100.55% |
| Shares Change (QoQ) | -1.19% |
| Owned by Insiders (%) | 0.57% |
| Owned by Institutions (%) | 55.33% |
| Float | 59.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 42.00 |
| Forward PS | 9.37 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 50.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.58
| Current Ratio | 2.58 |
| Quick Ratio | 2.42 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -85.74 |
Financial Efficiency
Return on equity (ROE) is -2,888.71% and return on invested capital (ROIC) is -135.71%.
| Return on Equity (ROE) | -2,888.71% |
| Return on Assets (ROA) | -66.06% |
| Return on Invested Capital (ROIC) | -135.71% |
| Return on Capital Employed (ROCE) | -136.80% |
| Revenue Per Employee | $171,526 |
| Profits Per Employee | -$3.09M |
| Employee Count | 78 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Verastem has paid $185,000 in taxes.
| Income Tax | 185,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +142.67% in the last 52 weeks. The beta is 0.42, so Verastem's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | +142.67% |
| 50-Day Moving Average | 8.81 |
| 200-Day Moving Average | 7.08 |
| Relative Strength Index (RSI) | 56.19 |
| Average Volume (20 Days) | 2,589,215 |
Short Selling Information
The latest short interest is 17.63 million, so 22.85% of the outstanding shares have been sold short.
| Short Interest | 17.63M |
| Short Previous Month | 18.09M |
| Short % of Shares Out | 22.85% |
| Short % of Float | 29.77% |
| Short Ratio (days to cover) | 8.03 |
Income Statement
In the last 12 months, Verastem had revenue of $13.38 million and -$241.11 million in losses. Loss per share was -$3.98.
| Revenue | 13.38M |
| Gross Profit | 11.39M |
| Operating Income | -160.24M |
| Pretax Income | -240.92M |
| Net Income | -241.11M |
| EBITDA | -159.81M |
| EBIT | -160.24M |
| Loss Per Share | -$3.98 |
Full Income Statement Balance Sheet
The company has $137.71 million in cash and $89.48 million in debt, giving a net cash position of $48.23 million or $0.62 per share.
| Cash & Cash Equivalents | 137.71M |
| Total Debt | 89.48M |
| Net Cash | 48.23M |
| Net Cash Per Share | $0.62 |
| Equity (Book Value) | -15.53M |
| Book Value Per Share | -0.23 |
| Working Capital | 94.34M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -132.65M |
| Capital Expenditures | n/a |
| Free Cash Flow | -132.65M |
| FCF Per Share | -$1.72 |
Full Cash Flow Statement Margins
| Gross Margin | 85.14% |
| Operating Margin | -1,197.73% |
| Pretax Margin | -1,800.74% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Verastem does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -100.55% |
| Shareholder Yield | -100.55% |
| Earnings Yield | -33.37% |
| FCF Yield | -18.36% |
Analyst Forecast
The average price target for Verastem is $13.38, which is 44.34% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.38 |
| Price Target Difference | 44.34% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 117.76% |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 1, 2023. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jun 1, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
Verastem has an Altman Z-Score of -10.27 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.27 |
| Piotroski F-Score | 2 |